2026 Winter Cancer Symposium | An Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies

2026 Winter Cancer Symposium | An Upfront Treatment for Common Ovarian Cancer (High Grade Serous) Versus Rare Histologies

Overview

NA

Target Audience

Physicians
Nurses
Pharmacists
Physician Associates

This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.

Faculty

David O’Malley, MD

Date of Release

March 9th, 2026